Abstract
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have